Surgery Partners delivers shareholders enviable 32 percent CAGR over 5 years, surging 5.8 percent in the last week alone
| SGRY Stock | USD 23.81 0.03 0.13% |
Slightly above 61% of Surgery Partners' investor base is looking to short. The analysis of overall sentiment of trading Surgery Partners stock suggests that many investors are alarmed at this time. Surgery Partners' investing sentiment can be driven by a variety of factors including economic data, Surgery Partners' earnings reports, geopolitical events, and overall market trends.
Surgery |
For many, the main point of investing in the stock market is to achieve spectacular returns. And highest quality...
Read at simplywall.st
 |
Surgery Partners Fundamental Analysis
We analyze Surgery Partners' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Surgery Partners using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Surgery Partners based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Current Liabilities
Current Liabilities Comparative Analysis
Surgery Partners is currently under evaluation in current liabilities category among its peers. Current Liabilities is the company's short term debt. This usually includes obligations that are due within the next 12 months or within one fiscal year. Current liabilities are very important in analyzing a company's financial health as it requires the company to convert some of its current assets into cash.
Surgery Partners Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Surgery Partners stock to make a market-neutral strategy. Peer analysis of Surgery Partners could also be used in its relative valuation, which is a method of valuing Surgery Partners by comparing valuation metrics with similar companies.
Peers
Surgery Partners Related Equities
| NHC | National HealthCare | 1.73 | ||||
| EHAB | Enhabit | 1.68 | ||||
| PNTG | Pennant | 1.22 | ||||
| HCSG | Healthcare Services | 0.97 | ||||
| INNV | InnovAge Holding | 0.62 | ||||
| ADUS | Addus HomeCare | 0.20 | ||||
| SEM | Select Medical | 0.38 | ||||
| EHC | Encompass Health | 0.52 | ||||
| ENSG | Ensign | 0.72 | ||||
| UHS | Universal Health | 1.92 | ||||
| CCM | Concord Medical | 8.06 |
Additional Tools for Surgery Stock Analysis
When running Surgery Partners' price analysis, check to measure Surgery Partners' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Surgery Partners is operating at the current time. Most of Surgery Partners' value examination focuses on studying past and present price action to predict the probability of Surgery Partners' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Surgery Partners' price. Additionally, you may evaluate how the addition of Surgery Partners to your portfolios can decrease your overall portfolio volatility.